Go Pro

Nasus Pharma (NSRX) Earnings Date, Estimates & Call Transcripts

Nasus Pharma logo
$3.73 -0.02 (-0.53%)
As of 09/4/2026 04:10 PM Eastern

Nasus Pharma Earnings Summary

Nasus Pharma released Q2 2026 earnings on August 17, 2026, reporting an EPS of -$0.27. With a trailing EPS of $0.00, Nasus Pharma's earnings are expected to grow next year, from ($0.93) to ($0.85) per share.

Q2 2026 Earnings Resources

Get Nasus Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nasus Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Nasus Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.27-$0.27-$0.27
Q2 20261-$0.18-$0.18-$0.18
Q3 20261-$0.24-$0.24-$0.24
Q4 20261-$0.24-$0.24-$0.24

Nasus Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/17/2026Q2 2026--$0.27--$0.27--

Nasus Pharma Earnings - Frequently Asked Questions

Nasus Pharma (NYSEAMERICAN:NSRX) last announced its quarterly earning data on Monday, August 17, 2026. Learn more on NSRX's earnings history.

Nasus Pharma (NYSEAMERICAN:NSRX) has a recorded net income of -$5.86 million. NSRX has generated $0.00 earnings per share over the last four quarters.

Nasus Pharma's earnings are expected to grow from ($0.93) per share to ($0.85) per share in the next year.


Earnings data for NYSEAMERICAN:NSRX is sourced from Fiscal.ai, with the most recent quarter reported on 8/17/2026. New results are added as companies report their earnings.
From Our Partners